Screening compound: LJDXCIUIRGQNJI-FQEVSTJZSA-N

Screening compound: LJDXCIUIRGQNJI-FQEVSTJZSA-N
Screening compound: LJDXCIUIRGQNJI-FQEVSTJZSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
LJDXCIUIRGQNJI-FQEVSTJZSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P681-0445

Molecular Formula

C20H19N3O4S (C20 H19 N3 O4 S)

Compound Name

3-({5-methoxy-1-methyl-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidin]-1'-yl}sulfonyl)benzonitrile

IUPAC name

3-({5-methoxy-1-methyl-2-oxo-12-dihydrospiro[indole-33'-pyrrolidin]-1'-yl}sulfonyl)benzonitrile

SMILES

CN(C(C1(CC2)CN2S(c2cc(C#N)ccc2)(=O)=O)=O)c(cc2)c1cc2OC

InChI

InChI=1S/C20H19N3O4S/c1-22-18-7-6-15(27-2)11-17(18)20(19(22)24)8-9-23(13-20)28(25,26)16-5-3-4-14(10-16)12-21/h3-7,10-11H,8-9,13H2,1-2H3/t20-/m0/s1

InChI Key

LJDXCIUIRGQNJI-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27611674

LJDXCIUIRGQNJI-FQEVSTJZSA-N in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS MPO Library (28609 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Nuclear receptors
Structure:
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with LJDXCIUIRGQNJI-FQEVSTJZSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound LJDXCIUIRGQNJI-FQEVSTJZSA-N?
Check Price and Availability of LJDXCIUIRGQNJI-FQEVSTJZSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of LJDXCIUIRGQNJI-FQEVSTJZSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for LJDXCIUIRGQNJI-FQEVSTJZSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for LJDXCIUIRGQNJI-FQEVSTJZSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of LJDXCIUIRGQNJI-FQEVSTJZSA-N available by request